Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of July 14, 2026, BJDX trades at $1.20 with a market cap of $1.50M and a P/E ratio of -0.08. BJDX moved -14.48% today. Year to date, BJDX is -58.10%; over the trailing twelve months it is -80.82%. Its 52-week range spans $1.03 to $40.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BJDX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.20 |
| Market Cap | $1.50M |
| P/E Ratio | -0.08 |
| EPS | $-15.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.80 |
| 52-Week Low | $1.03 |
| Volume | 939.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.85M |
| Gross Margin | 0.00% |
BJDX analyst coverage data. Average price target: $0.00.